| Protein FDR Confidence: Combined | Accession | Description | Exp. q-value: Combined | Sum PEP Score | Coverage [%] | # Peptides | # PSMs | # Unique Peptides | # AAs | MW [kDa] | calc. pI | Abundance Ratio: (B Stem KO) / (B Stem WT) | Abundance Ratio (log2): (B Stem KO) / (B Stem WT) | Abundance Ratio P-Value: (B Stem KO) / (B Stem WT) | Abundance Ratio Adj. P-Value: (B Stem KO) / (B Stem WT) | Abundance Ratio Variability [%]: (B Stem KO) / (B Stem WT) | Abundances (Grouped): B Stem KO | Abundances (Grouped): B Stem WT | Abundances (Grouped) CV [%]: B Stem KO | Abundances (Grouped) CV [%]: B Stem WT | Abundances (Scaled): F2: 129, Sample, B Stem KO, 1 | Abundances (Scaled): F2: 130, Sample, B Stem KO, 2 | Abundances (Scaled): F2: 131, Sample, B Stem KO, 3 | Abundances (Scaled): F2: 126, Sample, B Stem WT, 1 | Abundances (Scaled): F2: 127, Sample, B Stem WT, 2 | Abundances (Scaled): F2: 128, Sample, B Stem WT, 3 | Abundances (Normalized): F2: 129, Sample, B Stem KO, 1 | Abundances (Normalized): F2: 130, Sample, B Stem KO, 2 | Abundances (Normalized): F2: 131, Sample, B Stem KO, 3 | Abundances (Normalized): F2: 126, Sample, B Stem WT, 1 | Abundances (Normalized): F2: 127, Sample, B Stem WT, 2 | Abundances (Normalized): F2: 128, Sample, B Stem WT, 3 | Abundance: F2: 129, Sample, B Stem KO, 1 | Abundance: F2: 130, Sample, B Stem KO, 2 | Abundance: F2: 131, Sample, B Stem KO, 3 | Abundance: F2: 126, Sample, B Stem WT, 1 | Abundance: F2: 127, Sample, B Stem WT, 2 | Abundance: F2: 128, Sample, B Stem WT, 3 | Abundances Count: F2: 129, Sample, B Stem KO, 1 | Abundances Count: F2: 130, Sample, B Stem KO, 2 | Abundances Count: F2: 131, Sample, B Stem KO, 3 | Abundances Count: F2: 126, Sample, B Stem WT, 1 | Abundances Count: F2: 127, Sample, B Stem WT, 2 | Abundances Count: F2: 128, Sample, B Stem WT, 3 | Biological Process | Cellular Component | Molecular Function | Pfam IDs | Entrez Gene ID | Gene Symbol | Chromosome | Reactome Pathways | Ensembl Gene ID | KEGG Pathways | WikiPathways | # Razor Peptides | Modifications |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| High | O35633 | Vesicular inhibitory amino acid transporter OS=Mus musculus OX=10090 GN=Slc32a1 PE=1 SV=3 | 0 | 106.937 | 28 | 13 | 41 | 13 | 525 | 57.3 | 6.64 | 1.051 | 0.07 | 0.681872068 | 0.994992347 | 2.54 | 102.5 | 97.5 | 14.14 | 10.69 | 90.3 | 117.9 | 97 | 92 | 110.4 | 92.4 | 4513.4 | 5891.4 | 4847.9 | 4595.3 | 5513.6 | 4614.7 | 3949.5 | 5605.1 | 4847.9 | 4060.7 | 5152 | 4454.7 | 17 | 18 | 18 | 18 | 18 | 18 | transport | membrane | transporter activity | Pf01490 | 22348 | Slc32a1 | 2 | "Transport of inorganic cations/anions and amino acids/oligopeptides; GABA synthesis, release, reuptake and degradation" | ENSMUSG00000037771.11 | Morphine addiction; Retrograde endocannabinoid signaling; GABAergic synapse; Nicotine addiction; Synaptic vesicle cycle | 0 |